Phase I study of bevacizumab, sorafenib, and low-dose cyclophosphamide (CYC) in children and young adults with refractory solid tumors.

被引：2
|
作者：
Santana, V. M. [1 ]
Baker, S. D. [1 ]
McCarville, B. [1 ]
Stewart, C. F. [1 ]
Wu, J. [1 ]
Billups, C. [1 ]
Spunt, S. L. [1 ]
Furman, W. L. [1 ]
McGregor, L. M. [1 ]
Hu, S. [1 ]
Panetta, J. C. [1 ]
Reddick, W. E. [1 ]
Davidoff, A. [1 ]
Leung, W. H. [1 ]
Navid, F. [1 ]
机构：
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.9500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9500
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I study of danusertib (D) in combination with bevacizumab (B) in solid tumors.
    Rosen, P. J.
    Tolcher, A. W.
    Lee, P.
    Smitley, M.
    Fuerst, M.
    Spinelli, R.
    Crippa, S.
    Jannuzzo, M. G.
    Comis, S.
    Papadopoulos, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
    Rangwala, Fatima A.
    Bendell, Johanna C.
    Kozloff, Mark
    Arrowood, Christy
    Meadows, Jennifer
    Tourt-Uhlig, Sandra Ellen
    Murphy, Jennifer
    Meadows, Kellen
    Morse, Michael
    Uronis, Hope Elizabeth
    Hsu, Shiaowen David
    Zafar, Yousuf
    Hurwitz, Herbert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [23] Phase I/II study of low-dose cyclophosphamide, tumor-associated peptide antigen-pulsed dendritic cell and low dose GM-CSF for solid and hematological tumors.
    Mirandola, Leonardo
    Figueroa, Jose A.
    Diane Duyen Thuy Nguyen
    Dahlbeck, Scott
    Chiriva-Internati, Maurizio
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [24] Phase I trial and pharmacokinetic (PK) study of satraplatin in children and young adults with refractory solid tumors including brain tumors
    Akshintala, Srivandana
    Marcus, Leigh
    Warren, Katherine E.
    Murphy, Robert F.
    Goodspeed, Wendy J.
    Goodwin, Anne
    Brewer, Carmen C.
    Zalewski, Christopher
    King, Kelly A.
    Kim, AeRang
    Widemann, Brigitte C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group
    Kim, AeRang
    Widemann, Brigitte C.
    Krailo, Mark
    Jayaprakash, Nalini
    Fox, Elizabeth
    Weigel, Brenda
    Blaney, Susan M.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (09) : 1562 - 1566
  • [26] Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors
    Aspeslagh, Sandrine
    Awada, Ahmad
    Matos-Pita, Arturo S.
    Aftimos, Philippe
    Bahleda, Ratislav
    Varga, Andrea
    Soria, Jean-Charles
    ANTI-CANCER DRUGS, 2016, 27 (10) : 1021 - 1027
  • [27] Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid Tumors
    Chiorean, E. Gabriela
    Perkins, Susan M.
    Strother, R. Matthew
    Younger, Anne
    Funke, Jennifer M.
    Shanda, Safi G.
    Hahn, Noah M.
    Sandrasegaran, Kumar
    Jones, David R.
    Skaar, Todd C.
    Schneider, Bryan P.
    Sweeney, Christopher J.
    Matei, Daniela E.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2155 - 2162
  • [28] A PHASE I DOSE ESCALATION STUDY OF BXQ-350 IN CHILDREN AND YOUNG ADULTS WITH RELAPSED SOLID TUMORS
    Setty, Bhuvana
    Cripe, Timothy
    DeWire-Schottmiller, Mariko
    Curry, Richard
    AdelBaki, Mohamed
    NEURO-ONCOLOGY, 2020, 22 : 289 - 289
  • [29] POE14-01: A PHASE I STUDY OF CARFILZOMIB IN COMBINATION WITH CYCLOPHOSPHAMIDE AND ETOPOSIDE FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED/REFRACTORY LEUKEMIAS OR SOLID TUMORS
    Boklan, Jessica
    Narendran, Aru
    Bielamowicz, Kevin
    Trippett, Tanya
    Brown, Valerie
    Dubois, Steven
    Eshun, Francis
    Gelfond, Jonathan
    Zomet, Ativ
    Lacayo, Norman
    Langevin, Anne-Marie
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S117 - S118
  • [30] A phase I study of sirolimus in combination with metronomic therapy in children with recurrent and refractory solid/CNS tumors.
    Qayed, Muna
    Cash, Thomas
    Tighiouart, Mourad
    MacDonald, Tobey
    Goldsmith, Kelly C.
    Kean, Leslie S.
    Church, Patty
    Katzenstein, Howard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345